FILOSTO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 10.673
AS - Asia 6.435
EU - Europa 3.177
SA - Sud America 1.504
AF - Africa 145
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.947
Nazione #
US - Stati Uniti d'America 10.439
SG - Singapore 2.619
CN - Cina 1.335
BR - Brasile 1.278
HK - Hong Kong 954
IT - Italia 555
VN - Vietnam 457
UA - Ucraina 356
DE - Germania 327
BD - Bangladesh 321
FR - Francia 310
GB - Regno Unito 297
PL - Polonia 288
FI - Finlandia 276
RU - Federazione Russa 269
TR - Turchia 261
IE - Irlanda 218
IN - India 134
CA - Canada 111
AR - Argentina 84
MX - Messico 73
IQ - Iraq 64
SE - Svezia 63
ZA - Sudafrica 61
AT - Austria 49
NL - Olanda 46
JP - Giappone 45
ID - Indonesia 36
PK - Pakistan 32
EC - Ecuador 29
UZ - Uzbekistan 28
PY - Paraguay 27
ES - Italia 26
CZ - Repubblica Ceca 25
VE - Venezuela 22
CL - Cile 20
SA - Arabia Saudita 20
CO - Colombia 19
EG - Egitto 16
IL - Israele 16
AE - Emirati Arabi Uniti 15
CH - Svizzera 14
LT - Lituania 14
KE - Kenya 13
MA - Marocco 12
UY - Uruguay 12
PE - Perù 11
JO - Giordania 10
NP - Nepal 10
TW - Taiwan 10
TN - Tunisia 9
CR - Costa Rica 8
NG - Nigeria 8
PH - Filippine 8
BE - Belgio 7
GR - Grecia 7
JM - Giamaica 7
LB - Libano 7
AU - Australia 6
AZ - Azerbaigian 6
BH - Bahrain 6
ET - Etiopia 6
OM - Oman 6
PA - Panama 6
AL - Albania 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KZ - Kazakistan 5
SN - Senegal 5
DZ - Algeria 4
GE - Georgia 4
GT - Guatemala 4
IR - Iran 4
MU - Mauritius 4
PS - Palestinian Territory 4
BG - Bulgaria 3
BY - Bielorussia 3
EU - Europa 3
KH - Cambogia 3
LV - Lettonia 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
KR - Corea 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BM - Bermuda 1
BN - Brunei Darussalam 1
Totale 21.929
Città #
Fairfield 1.312
Singapore 1.268
Ashburn 1.107
Hong Kong 952
Woodbridge 685
Seattle 602
Houston 544
The Dalles 480
Wilmington 453
San Jose 448
Cambridge 431
Princeton 403
New York 329
Warsaw 285
Jacksonville 276
Lauterbourg 251
Los Angeles 238
Beijing 231
Istanbul 222
Dublin 216
Ann Arbor 214
Helsinki 191
Council Bluffs 173
Chandler 150
Ho Chi Minh City 145
Des Moines 135
Dallas 125
Buffalo 114
Moscow 113
Redondo Beach 104
São Paulo 93
San Diego 92
Hanoi 91
Munich 83
Brescia 78
London 78
Santa Clara 67
Chicago 59
Milan 54
Shanghai 54
Nanjing 51
Nuremberg 47
Boardman 43
Rio de Janeiro 43
San Francisco 41
Turku 40
Tokyo 39
Atlanta 38
Montreal 36
Orem 34
Brooklyn 33
Johannesburg 31
Rome 30
Toronto 30
Lappeenranta 28
Denver 27
Frankfurt am Main 27
Guangzhou 27
Porto Alegre 27
Tashkent 27
Belo Horizonte 26
Pune 25
Vienna 25
Baghdad 23
Romola 23
Dearborn 22
Dhaka 22
Phoenix 22
Poplar 22
Chennai 21
Curitiba 20
Da Nang 20
Manchester 20
Naples 20
Tianjin 20
Brasília 19
Stockholm 19
Changsha 18
Boston 17
Mexico City 17
Norwalk 17
Amsterdam 16
Nanchang 16
Goiânia 15
Haiphong 15
Jinan 15
Shenyang 15
Charlotte 14
Guarulhos 14
Guayaquil 14
New Delhi 14
Salt Lake City 14
Cape Town 12
Dong Ket 12
Lancaster 12
Thái Nguyên 12
Washington 12
Biên Hòa 11
Brno 11
Jakarta 11
Totale 14.338
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 349
Very late-onset friedreich ataxia with laryngeal dystonia 316
A Novel Mutation in the Stalk Domain of KIF5A Causes a Slowly Progressive Atypical Motor Syndrome 263
COVID-19 impact on consecutive neurological patients admitted to the emergency department 257
A complex craniovertebral junction malformation in a patient with late onset glycogenosis 2 254
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 207
A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement. 190
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 184
A new mutation in the mitochondrial tRNAAla gene in a patient with ophthalmoplegia and dysphagia 175
A novel mitochondrial tRNA(Ala) gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease. 167
Small nerve fiber pathology in critical illness 164
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 164
Gold Coast Criteria in ALS Diagnosis: A Real-World Experience 163
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 162
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 155
Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy 155
Critical illness myopathy 155
A novel CAPN1 mutation causes a pure hereditary spastic paraplegia in an Italian family 153
Coffee and amyotrophic lateral sclerosis: A possible preventive role 148
Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study 144
Snake-Eye Myelopathy and Surgical Prognosis: Case Series and Systematic Literature Review 142
Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II 130
The brain in late-onset glycogenosis II: a structural and functional MRI study. 129
Novel mitochondrial tRNALeu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 129
Mitochondrial DNA-related disorders. 127
Neuropathology of mitochondrial diseases. 127
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 127
C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age 126
Muscle pain in mitochondrial diseases: a picture from the Italian network 124
Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study 123
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 122
MR Neurography in Diagnosing Nondiabetic Lumbosacral Radiculoplexus Neuropathy 121
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 121
Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a NovelTYMPMutation: The Need for Early Diagnosis 120
Human leukocyte antigens class II in CIDP spectrum neuropathies 119
Editorial: Iron and Neurodegeneration 118
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 114
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group 113
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial) 110
SELENON-related myopathy as a cause of acute respiratory failure in middle age: a case report 109
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 109
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 109
Magnetic resonance imaging of the peripheral nerve 108
Impact of environmental factors and physical activity on disability and quality of life in CIDP 107
Late and severe myopathy in a patient with glycogenosis VII worsened by cyclosporin and amiodarone 106
Psychosocial impact of sport activity in neuromuscular disorders 106
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: Report of a family 105
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort 103
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 102
Advances in quantitative imaging of genetic and acquired myopathies: Clinical applications and perspectives 102
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE-MTDPS1) 102
Vaccination recommendations for patients with neuromuscular disease 100
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis 99
A 5-year clinical follow-up study from the Italian National Registry for FSHD 99
Muscle biopsy displaying "double trouble" pathology: Combined features of periodic paralysis and dermatomyositis 99
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 98
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 98
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 98
Clinical spectrum and evolution of monoclonal gammopathy-associated neuropathy: An observational study 96
A mobile app for patients with Pompe disease and its possible clinical applications 96
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 94
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 94
Alterazioni delle fibre sensitive di piccolo calibro intra-epidermiche in pazienti con critical illness myopathy and neuropathy. Dati preliminari. 93
Prevalence of asymptomatic vertebral fractures in late-onset pompe disease 93
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1) 93
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the ACADVL Gene 92
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy 92
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 92
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: A simple test to identify this condition 91
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 90
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 90
A Comprehensive Update on Late-Onset Pompe Disease 89
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 89
Late-onset glycogen storage disease type 2 89
On the Comparison of Markov Chains-based Models in Process Mining for Healthcare: A Case Study 88
The genetic basis of undiagnosed muscular dystrophies and myopathies 87
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genome 86
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 86
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 86
A novel mutation in motor domain of KIF5A associated with an HSP/axonal neuropathy phenotype 86
The role of mitochondria in neurodegenerative diseases 85
ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: A clinical, biochemical and molecular study 85
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy 85
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE 84
Strategies for treating mitochondrial disorders: An update 84
Mitochondrial diseases: Advances and issues 83
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 83
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy 82
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1c 81
A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody 81
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 80
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 80
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 80
Imaging of the muscle 79
Progress in enzyme replacement therapy in glycogen storage disease type II 79
Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis 79
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 78
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 78
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 78
Reversible upper limb muscle weakness with selective loss of thick filaments 78
Totale 11.840
Categoria #
all - tutte 142.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 0 0 290
2021/20221.225 27 293 25 39 11 81 137 91 85 57 115 264
2022/2023860 223 22 22 21 50 266 3 53 103 13 36 48
2023/20241.565 61 29 146 57 56 267 47 45 487 27 38 305
2024/20253.934 28 11 48 503 459 322 268 87 550 360 775 523
2025/20268.979 731 1.283 719 1.287 716 497 1.179 439 504 792 518 314
Totale 22.290